Published in

Taylor and Francis Group, Leukemia & Lymphoma, 12(50), p. 1958-1963, 2009

DOI: 10.3109/10428190903186486

Links

Tools

Export citation

Search in Google Scholar

A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia

Journal article published in 2009 by Thomas S. Lin, Wendy Stock, Huiping Xu, Mitch A. Phelps, Margaret S. Lucas, Sara K. Guster, Bruce R. Briggs, Carolyn Cheney, Pierluigi Porcu, Ian W. Flinn ORCID, Michael R. Grever, James T. Dalton, John C. Byrd
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO